title: Time until relapse in tuberculosis treatment trials: implication for phase 3 trial design.
authors.forename: John L
authors.initials: JL
authors.lastname: Johnson
authors.forename: Bonnie A
authors.initials: BA
authors.lastname: Thiel
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents